Wigginton Jon Marc

Sr VP, Clinical Dev. & CMO at MGNX

Sold, on record
$3.3M
Dollars the filings state
Form 4 sales
16
Latest Jan 17, 2018
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MGNXMACROGENICS INCSr VP, Clinical Dev. & CMO

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MGNXUnusual
    Jul 1, 2016 2016

    Sold 5,000 shares at $27.22 ($136k)

    Wigginton Jon Marc, Sr VP Clinical Dev & CMO

    Sold 100% of holdings ($136k position)0 shares left1x usual sizeFiling

  2. 2 Form 4 sale MGNXUnusual
    Aug 1, 2016 +31 days

    Sold 20,000 shares at $30.78 ($616k)

    Wigginton Jon Marc, Sr VP Clinical Dev & CMO

    Sold 100% of holdings ($616k position)0 shares left4x usual sizeFiling

  3. 3 Form 4 sale MGNXUnusual
    Oct 3, 2016 +63 days

    Sold 10,000 shares at $29.34 ($293k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 100% of holdings ($293k position)0 shares left2x usual sizeFiling

  4. 4 Form 4 sale MGNXUnusual
    Apr 19, 2017 +198 days

    Sold 15,000 shares at $20.00 ($300k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 33.3% of holdings ($900k position)30,000 shares left1.5x usual sizeFiling

  5. 5 Form 4 sale MGNXPlan not stated
    Jun 5, 2017 +47 days

    Sold 5,000 shares at $20.00 ($100k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 14.3% of holdings ($700k position)30,000 shares left0.5x usual sizeFiling

  6. 6 Form 4 sale MGNXUnusual
    Oct 25, 2017 +142 days

    Sold 10,000 shares at $20.00 ($200k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 25% of holdings ($800k position)30,000 shares left1x usual sizeFiling

  7. 7 Form 4 sale MGNXPlan not stated
    Nov 21, 2017 +27 days

    Sold 5,000 shares at $20.00 ($100k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 14.3% of holdings ($700k position)30,000 shares left0.5x usual sizeFiling

  8. 8 Form 4 sale MGNXPlan not stated
    Jan 17, 2018 +57 days

    Sold 5,000 shares at $20.00 ($100k)

    Wigginton Jon Marc, Sr VP, Clinical Dev. & CMO

    Sold 14.3% of holdings ($700k position)30,000 shares left0.5x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (16)

Form 144 notices and Form 4 sales by Wigginton Jon Marc
Source
Jan 17, 2018Jan 18, 2018MGNXSr VP, Clinical Dev. & CMOForm 4 sale5,000$100k14.3%Plan not statedSEC
Nov 21, 2017Nov 21, 2017MGNXSr VP, Clinical Dev. & CMOForm 4 sale5,000$100k14.3%Plan not statedSEC
Oct 25, 2017Oct 26, 2017MGNXSr VP, Clinical Dev. & CMOForm 4 sale10,000$200k25.0%UnusualSEC
Jun 5, 2017Jun 6, 2017MGNXSr VP, Clinical Dev. & CMOForm 4 sale5,000$100k14.3%Plan not statedSEC
Apr 19, 2017Apr 20, 2017MGNXSr VP, Clinical Dev. & CMOForm 4 sale15,000$300k33.3%UnusualSEC
Oct 3, 2016Oct 5, 2016MGNXSr VP, Clinical Dev. & CMOForm 4 sale10,000$293k100.0%UnusualSEC
Aug 1, 2016Aug 3, 2016MGNXSr VP Clinical Dev & CMOForm 4 sale20,000$616k100.0%UnusualSEC
Jul 1, 2016Jul 6, 2016MGNXSr VP Clinical Dev & CMOForm 4 sale5,000$136k100.0%UnusualSEC
Jan 4, 2016Jan 6, 2016MGNXSr VP, ClinicalForm 4 sale10,000$296k100.0%UnusualSEC
Oct 1, 2015Oct 2, 2015MGNXSr VP, ClinicalForm 4 sale5,000$106k100.0%UnusualSEC
Aug 3, 2015Aug 3, 2015MGNXSr VP, ClinicalForm 4 sale10,000$372k100.0%UnusualSEC
Jul 1, 2015Jul 1, 2015MGNXSr VP, ClinicalForm 4 sale5,000$186k100.0%UnusualSEC
Apr 1, 2015Apr 3, 2015MGNXSr VP, ClinicalForm 4 sale5,000$154k100.0%UnusualSEC
Feb 2, 2015Feb 3, 2015MGNXSr VP, ClinicalForm 4 sale5,000$155k100.0%UnusualSEC
Oct 1, 2014Oct 2, 2014MGNXSr V.P., ClinicalForm 4 sale5,000$102k100.0%UnusualSEC
Aug 18, 2014Aug 19, 2014MGNXSenior VP, Clinical Dev.Form 4 sale5,000$103k100.0%UnusualSEC